In women with polycystic ovary syndrome and obesity, loss of intra-abdominal fat is associated with resumption of ovulation by Kuchenbecker, W.K.H. et al.
  
 University of Groningen
In women with polycystic ovary syndrome and obesity, loss of intra-abdominal fat is
associated with resumption of ovulation
Kuchenbecker, W.K.H.; Groen, H.; van Asselt, S.J.; Bolster, J.H.T.; Zwerver, J.; Slart, R.H.J.;
van der Jagt, E.J.; Kobold, A.C.M.; Wolffenbuttel, B.H.R.; Land, J.A.
Published in:
Human Reproduction
DOI:
10.1093/humrep/der229
IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2011
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Kuchenbecker, W. K. H., Groen, H., van Asselt, S. J., Bolster, J. H. T., Zwerver, J., Slart, R. H. J., ... Hoek,
A. (2011). In women with polycystic ovary syndrome and obesity, loss of intra-abdominal fat is associated
with resumption of ovulation. Human Reproduction, 26(9), 2505-2512.
https://doi.org/10.1093/humrep/der229
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
ORIGINAL ARTICLE Reproductive endocrinology
In women with polycystic ovary
syndrome and obesity, loss
of intra-abdominal fat is associated
with resumption of ovulation
Walter K.H. Kuchenbecker1,8,*, Henk Groen2, Sophie J. van Asselt1,
Johanna H.T. Bolster1, J. Zwerver3, Riemer H.J. Slart4, Erik J. vd Jagt5,
Anneke C. Muller Kobold6, Bruce H.R. Wolffenbuttel 7,
Jolande A. Land1, and Annemieke Hoek1
1Department of Obstetrics and Gynaecology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The
Netherlands 2Department of Epidemiology, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The
Netherlands 3Center for Sports Medicine, University Medical Center Groningen, University of Groningen, 9700 RB Groningen, The
Netherlands 4Department of Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, 9700
RB Groningen, The Netherlands 5Department of Radiology, University Medical Center Groningen, University of Groningen, 9700 RB
Groningen, The Netherlands 6Department of Laboratory Medicine, University Medical Center Groningen, University of Groningen, 9700 RB
Groningen, The Netherlands 7Department of Endocrinology, University Medical Center Groningen, University of Groningen, 9700 RB
Groningen, The Netherlands 8Department of Obstetrics and Gynaecology, Isala Clinics, Dr. van Heesweg 2, 8000 GK, Zwolle,
The Netherlands
*Correspondence address. Department of Obstetrics and Gynaecology, Isala Clinics, Dr. van Heesweg 2, 8000 GK, Zwolle,
The Netherlands. Tel: +31-38-4247010; Fax: +31-38-4548405; E-mail: w.k.h.kuchenbecker@isala.nl
Submitted on April 9, 2011; resubmitted on June 14, 2011; accepted on June 16, 2011
background: It is not clear why some anovulatory women with polycystic ovary syndrome (PCOS) and obesity resume ovulation and
others remain anovulatory after weight loss. The objective of this study was to compare the changes in body fat distribution and speciﬁcally
intra-abdominal fat (IAF) and subcutaneous abdominal fat (SAF) between a group of anovulatory women with PCOS and obesity who
resume ovulation (RO+) to those who remain anovulatory (RO2) during a lifestyle program.
methods: In a prospective pilot cohort study, anovulatory women with PCOS underwent a 6 month lifestyle program in a tertiary fertility
clinic. Body fat distribution was assessed by anthropometrics, dual-energy X-ray absorptiometry (DEXA) and single slice abdominal CT scan
at intake, after 3 months and after 6 months. Baseline-corrected changes over time were analysed using generalized estimating equations
longitudinal regression analysis.
results: In 32 anovulatory women with PCOS (age, 28+4 years; BMI, 37.5+ 5.0 kg/m2), there were no signiﬁcant baseline differences
in anthropometrics and biochemical assessment between 14 RO+ participants and 18 RO2 participants. RO+ women lost more weight
(6.3 versus 3.0%) and abdominal fat on DEXA (15.0 versus 4.3%) compared with RO2 women. Resumption of ovulation was associated
with early and consistent loss of IAF (12.4 versus 5.0% at 3 months and 18.5 versus 8.6% at 6 months). Loss of SAF between the RO+
women and the RO2 women was similar at 3 months (6.2 versus 6.1%) but did not change any further in RO2 women (6.1%) as it
did in RO+ women (11.4%) at 6 months.
conclusions: In anovulatory women with PCOS and obesity undergoing a lifestyle program, RO+ women lose more body weight and
abdominal fat on DEXA than RO2 women. In addition, this study shows that early and consistent loss of IAF is associated with resumption
of ovulation. Future studies should address the mechanisms behind these changes and should assess interventions aimed at loss of IAF to
facilitate resumption of ovulation.
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Introduction
The high prevalence of overweight [body mass index (BMI):
25–29.9 kg/m2] and obesity (BMI ≥30 kg/m2) is signiﬁcantly contri-
buting to the overall burden of disease worldwide, and the effect on
female reproduction is a growing additional concern (Haslam and
James, 2005; Nelson and Fleming, 2007). Overweight and obesity in
women is a main contributor to anovulation, with an exponential
increase in anovulation with increasing body weight (Rich-Edwards
et al., 1994; Green et al., 1988).
Increased abdominal fat accumulation (waist hip ratio .0.8 in
women) contributes to reproductive dysfunction (Zaadstra et al.,
1993; Wass et al., 1997; Pasquali et al., 2006) and these ﬁndings are
unchanged after correcting for BMI. Abdominal fat accumulation is
an indicator of higher metabolic risk proﬁle because it is associated
with insulin resistance (IR) (Despres et al., 2001). Hyperinsulinemia
in women with obesity contributes to anovulation by increased
ovarian androgen secretion (Pasquali et al., 2006; Bohler et al.,
2010), leading to arrest of follicle growth (Willis et al., 1996).
Loss of abdominal fat, on the other hand, is associated with
resumption of menstruation and ovulation in obese women with poly-
cystic ovary syndrome (PCOS) undergoing a weight loss program
(Huber-Buchholz et al., 1999; Thomson et al., 2008). It has been
shown that resumption of ovulation in anovulatory women with
obesity undergoing weight loss is mediated by improvement of IR
and decrease in free androgen levels (Guzick et al., 1994; Holte
et al., 1995; Pasquali et al., 2006). Abdominal fat consists of
intra-abdominal fat (IAF) and subcutaneous abdominal fat (SAF). In
study subjects with obesity who lost weight, loss of IAF had a
greater beneﬁcial effect on IR than loss of SAF (Park and Lee,
2005). The independent contribution of exercise to the improvement
of IR and loss of IAF is not clear because only few studies tried to
correct for diet and weight loss (Carroll and Dudﬁeld, 2004;
Christiansen et al., 2009; Hutchison et al., 2011).
It remains unexplained why some women remain anovulatory and
others resume ovulation after weight loss. It can be hypothesized
that speciﬁcally loss of IAF is required for improvement of IR,
decease in androgen levels and resumption of ovulation. We tested
this hypothesis by comparing the changes in body fat distribution,
and especially IAF and SAF, in a group of obese anovulatory women
with PCOS who resumed ovulation to those who remained anovula-
tory during a 6-month lifestyle program.
Materials and Methods
Population
In a pilot prospective cohort study, participants were recruited from
women with obesity and infertility attending the Fertility Clinic of the Uni-
versity Medical Center Groningen (UMCG) between 2005 and 2008. All
women with a BMI .29 kg/m2 who met the inclusion criteria (infertility
≥1 year, age ,38 years, partner with total motile sperm concentration
/ejaculate ≥10 million) were asked to participate in a 6-month lifestyle
program. The baseline data of this cohort of women before start of the
lifestyle program were published previously as a comparison of body fat
distribution characteristics between ovulatory and anovulatory infertile
women (Kuchenbecker et al., 2010). In the present study, assessing
changes during the lifestyle program, only anovulatory women with
PCOS were included in the analysis.
Participants were diagnosed as PCOS according to the Rotterdam con-
sensus diagnostic criteria (Rotterdam ESHRE/ASRM-Sponsored PCOS
Consensus Workshop Group, 2004) if two of the following criteria
were identiﬁed: anovulation, hyperandrogenemia (clinically or biochemi-
cally) or polycystic ovary morphology on ultrasound and after other endo-
crine causes of anovulation were excluded. Hyperandrogenemia was
deﬁned by a serum testosterone level .3.5 nmol/l or a free testosterone
level .62 pmol/l or when clinical hirsutism was present. No participant
received hormonal medications or metformin in the 3 months preceding
inclusion. All participants were Caucasian, except for one participant of
Asian origin.
Women with amenorrhea (cycle interval ≥6 months) were considered
anovulatory. Women with cycles ≤42 days in whom ovulation could not
be conﬁrmed by ultrasound monitoring, as well as women with menstrual
cycles between 42 days and 6 months kept a basal body temperature
(BBT) chart. Women with no BBT rise or a midluteal progesterone
level ≤15 nmol/l, 1 week after a BBT rise, were considered anovulatory.
In all study subjects, hyperprolactinemia, abnormal thyroid function, non-
classical 21-hydroxylase deﬁciency and an androgen-secreting tumor was
excluded.
During the lifestyle program, all women kept a BBT chart and a midlu-
teal progesterone level was assessed 1 week after a maintained tempera-
ture rise. Resumption of ovulation was deﬁned as a midluteal progesterone
level .15 nmol/l at least once, or by the occurrence of conception.
Participants who did not resume ovulation (RO2) and those who
resumed ovulation (RO+) but did not conceive remained in the
6-month lifestyle program. Women who conceived did not continue the
lifestyle program. Women who stopped the lifestyle program before
the sixth month were considered to be drop-outs. All drop-outs were
contacted by telephone 6 months after drop-out to inquire about self-
reported weight loss and conception.
The study was approved by the Medical Ethical Committee of the
UMCG and informed written consent was obtained from all subjects.
The lifestyle program of 6 months was based on the National Institute
of Health evidence report of the treatment of obesity (National Heart,
Lung and Blood Institute/National Institutes of Diabetes and Digestive
and Kidney diseases, 1998) and consisted of a combination of dietary
advice, increased physical activity and behaviour modiﬁcation.
Anthropometric assessment
Body weight (kg), height (cm), BMI [¼weight (kg) divided by height in
meters2], waist circumference (Wc ¼ waist measured at the narrowest
part of the torso located between the lower rib and the iliac crest), a
whole body DEXA scan (DEXA) and a single slice abdominal CT scan
(ssCT) were measured at baseline. All measurements were carried out
by the same observer. Bodyweight was recorded every 2 weeks and the
Wc, DEXA and the ssCT were measured again at month 3 and month
6 of the lifestyle program.
Total, trunk and abdominal fat mass was measured by DEXA, using a
Hologic A Discovery Bone Densitometer (Hologic, Inc., Bedford, MA,
USA). Total fat mass was determined for the whole body, and by using
computer programming, two regions (trunk and abdominal slice) were
speciﬁed and measured as mentioned in previous studies (Carmina
et al., 2007).
The ssCT consisting of three to four subslices was performed at the
level of the umbilicus for the measurement of the IAF and the SAF
(Seidell et al., 1990). The technique used to measure IAF and SAF was
published previously (Kuchenbecker et al., 2010). In short, the IAF and
SAF volume (cm3) was calculated by multiplying the IAF and SAF area
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(cm2) of each subslice with the subslice thickness (cm), and the mean
volume (cm3) of the subslices was recorded for analysis. All measurements
were performed by a single observer.
Pregnancy was excluded before each DEXA and ssCT scan by a urine
pregnancy test.
Biochemical assessment
Total testosterone, sex hormone-binding globulin (SHBG) and insulin were
measured after an overnight fast of 10 h at intake, after 3 months and after
6 months of the lifestyle program. The formula according to Vermeulen
(Vermeulen et al., 1999) was used to calculate free testosterone. The
exact measurement techniques used for the biochemical assessments
were published previously (Kuchenbecker et al., 2010).
Lifestyle program
All participants received individualized dietary advice aiming for reduction in
calorie intake of at least 500 kilocalories/day, but avoiding a total calorie
intake ,1200 kilocalories/day. An individualized exercise program was tai-
lored to the ability and personal and social circumstances of each participant.
Each participant kept a diet record and carried a pedometer SW-200 (New
Lifestyles, Lee’s Summit, USA) to record the amount of steps over 2-week
periods during the 6 months program. Individual guidance by a nurse prac-
titioner consisted of visits every 2 weeks, during which body weight was
measured and compliance was assessed by evaluating the diet and ped-
ometer records completed at home. In addition, the BBT chart was evalu-
ated and a serum midluteal progesterone level assessment was scheduled
if appropriate. By means of motivational counseling techniques, problems
of and resistance to lifestyle changes and behavior modiﬁcation were
addressed and advice was given (Levensky et al., 2007).
Statistical analysis
At the end of the lifestyle program, the participants were divided into
those who had resumed ovulation (RO+) and those who had not
resumed ovulation (RO2) and post hoc comparison was performed
between the two groups at baseline. The drop-outs were contacted by
telephone 6 months after drop-out. If no further weight loss or conception
after drop-out was reported, the drop-outs were analysed as part of the
RO2 group until the time of drop-out.
Between-group comparisons were performed using an independent
samples Student’s t-test for normally distributed continuous variables or
a Mann–Whitney U-test when the distribution was skewed. Normal dis-
tribution was tested using the Kolmogorov–Smirnov test. Changes over
time were analysed using generalized estimating equations (GEE) longitudi-
nal regression analysis with time, ovulatory status and an interaction term
of ovulatory status and time as the predictors. GEE makes maximum use
of the available measurements in a longitudinal design without the limit-
ations of complete case analysis. For interventions such as this lifestyle
program, complete case analysis does not reﬂect a real-life scenario and
poses the risk of negative selection since only those who do not conceive
or resume ovulation remain in the program. Baseline correction was per-
formed by including the measurement at T ¼ 0 of the respective par-
ameter as a covariate in the GEE analysis. Participants remained in the
GEE analysis until conception or drop-out. For this pilot study, no
sample size calculation could be performed. All analyses were performed
using SPSS, versions 16 and 17 (SPSS, Inc., Chicago, IL). Differences or
effects were considered statistically signiﬁcant if P, 0.05.
Results
Clinical characteristics of participants
Thirty two anovulatory women with PCOS and obesity were included
in the lifestyle program and their baseline data were recorded. During
the ﬁrst 3 months, the four women that conceived and four drop-outs
left the program, while another ﬁve women who resumed ovulation
continued the lifestyle program, therefore leaving 24 participants to
measure and record the data at 3 months. Out of the 24 participants
continuing the second 3 months of the lifestyle program, the three
women who conceived and six drop-outs left the program, leaving
15 participants to measure and record the data at 6 months.
None of the 10 drop-outs reported any further weight loss or con-
ception in the 6 months after drop-out. They were therefore analyzed
as part of the RO2 group. To ensure that the anthropometric and
biochemical measurements of the drop-outs did not differ from the
participants who completed the study, we performed a comparison
of the baseline characteristics between both groups (Table I). There
was no difference in age, BMI and anthropometric assessment
between the drop-outs and the participants who completed the
study. Except for signiﬁcantly higher free testosterone and total
........................................................................................
Table I Baseline characteristics of anovulatory women
with PCOS and obesity undergoing a 6-month lifestyle
program: comparison of the 10 drop-outs with the
participants who completed the lifestyle program.
Parameter Completed
(n 5 22)
Drop-out
(n5 10)
P-value
Age (years)a 28.9+4.1 27.5+2.9 0.35
BMI (kg/m2)a 37.8+5.2 36.7+4.3 0.56
Waist
circumference
(cm)a
114+13 110+9 0.36
Total fat
DEXA (kg)a
47.6+10.1 42.7+9.7 0.21
Trunk fat
DEXA (kg)a
23.8+5.8 21.7+4.9 0.34
Abdomen fat
DEXA (kg)a
4.7+1.3 3.9+1.3 0.14
IAF ssCT
(cm3)a
197+61 195+51 0.96
SAF ssCT
(cm3)a
1023+183 971+223 0.50
Testosterone
(pmol/l)b
3.7 (1.6–6.1) 4.7 (1.6–6.5) 0.04*
SHBG
(nmol/l)b
22 (10–38) 20 (8–36) 0.72
Free
testosterone
(pmol/l)b
87 (32–169) 116 (32–217) 0.04*
Fasting insulin
(pmol/l)b
170.3 (25.8–602.7) 193.0 (25.8–595.2) 0.80
Data expressed as amean+ SD using an independent sample Student’s t-test or as
bmedian, minimum and maximum using a Mann–Whitney U-test.
*Signiﬁcant at level P, 0.05.
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testosterone level in the drop-outs (P ¼ 0.04), there were no baseline
differences in the biochemical assessments between the drop-outs and
the participants who completed the study.
The baseline data of the RO+ (n ¼ 14) and RO2 (n ¼ 18) women
are shown in Table II. There was no difference in age, BMI,
anthropometric- and biochemical assessment at baseline between
the RO+ and RO2 women.
Changes during the lifestyle program
At the end of the lifestyle program, the participants were divided into
those who had resumed ovulation (RO+) and those who had not
resumed ovulation (RO2) and GEE analysis was performed on the
two groups. The unadjusted results of the measurements of the two
groups at baseline, month 3 and month 6 are presented in Table II.
The results of the GEE analyses of changes over time in body weight
and abdominal fat on DEXA are presented in Fig. 1. Since GEE was
performed with correction for baseline the values differ from those
in Table II. The total group of RO+ women lost more weight (6.3
versus 3.0% at 6 months, P ¼ 0.018, Fig. 1a) and abdominal fat on
DEXA (15.0 versus 4.3% at 6 months, P ¼ 0.025, Fig. 1b) compared
with the total group of RO2 women. Figure 2 shows that the RO+
women lost more IAF on ssCT between baseline and month 3 (12.4
versus 5.0%, P ¼ 0.002, Fig. 2a) and baseline and month 6 (18.5 versus
8.6%, P ¼ 0.005, Fig. 2a) compared with the RO2 women. For SAF
on ssCT, on the other hand, changes for RO+ women and RO2
women were similar between baseline and month three (6.2 versus
6.1%, P ¼ 0.946, Fig. 2b). Due to continued loss of SAF after 3
months in RO+ women, there was a difference in loss of SAF
between baseline and 6 months (11.4 versus 6.1%, P ¼ 0.031,
Fig. 2b) compared with RO2 women.
GEE analysis showed a non-signiﬁcant decrease of fasting insulin
(P ¼ 0.194) and free testosterone (P ¼ 0.086) in the RO+ women
compared with the RO2 women. The increase in pedometers
steps in RO+ women compared with RO2 women did not reach
statistical signiﬁcance.
Discussion
This study shows that in anovulatory women with PCOS and obesity
participating in a lifestyle program, resumption of ovulation was associ-
ated with more weight loss and loss of abdominal fat on DEXA.
Resumption of ovulation was associated with early and consistent
loss of IAF.
In anovulatory women, .5% loss of body weight is required for
resumption of ovulation (Kiddy et al., 1992; Guzick et al., 1994;
Clark et al., 1995; Holte et al., 1995; Huber-Buchholz et al., 1999).
Previous studies using DEXA to quantify the changes in abdominal
fat in women with PCOS undergoing a weight loss program indicated
that loss of abdominal fat is associated with resumption of ovulation
(Huber-Buchholz et al., 1999; Thomson et al., 2008). The present
study conﬁrms these ﬁndings, since the RO+ women lost 6.3% of
their body weight and 15.0% abdominal fat on DEXA during the life-
style program, as compared with 3.0% loss of body weight and 4.3%
loss of abdominal fat on DEXA in RO2 women. Compared with
RO2 women, RO+ women lost on average 4.0 kg more body
weight and 0.5 kg more abdominal fat on DEXA.
............................................ ............................................ .........................................
.............................................................................................................................................................................................
Table II Characteristics of 32 anovulatory women with PCOS and obesity undergoing a lifestyle program divided into
those who resumed ovulation (RO1) and those who remained anovulatory (RO2) at the end of 6 months.
Baseline Month 3 Month 6
RO1
(n5 14)
RO2
(n5 18)
P-value RO1
(n5 10)
RO2
(n5 14)
RO1 (n 5 7) RO2 (n 5 8)
Age (years)a 29.6+4.0 27.5+3.4 0.11
BMI (kg/m2)a 37.7+4.5 37.3+5.4 0.83 35.4+4.8 37.3+5.7 32.2+4.5 36.1+7.4
Waist circumference (cm)a 114+13 112+11 0.59 108+15 112+13 103+8 112+19
Total fat DEXA (kg)a 47.7+8.8 44.8+11.0 0.43 43.9+9.9 45.9+10.2 38.5+7.8 44.6+13.1
Trunk fat DEXA (kg)a 23.4+5.2 22.9+5.8 0.83 21.2+5.3 22.8+5.2 18.4+3.9 22.7+6.7
Abdomen fat DEXA (kg)a 4.6+1.4 4.4+1.4 0.58 4.2+1.5 4.5+1.4 3.6+1.3 4.6+1.5
IAF ssCT (cm3)a 191+41 201+69 0.63 156+26 206+70 133+19 192+94
SAF ssCT (cm3)a 1024+187 991+205 0.65 924+215 971+170 847+235 957+241
Total testosterone (pmol/
l)b
3.6 (1.6–5.5) 4.3 (2.8–6.5) 0.27 2.9 (2.3–3.8) 3.5 (2.4–6.0) 3.6 (3.3–3.9) 3.8 (2.4–5.0)
SHBG (nmol/l)b 23 (10–43) 20 (8–36) 0.33 22 (14–31) 23 (12–39) 31 (19–47) 19 (15–26)
Free testosterone (pmol/
l)b
84 (32–169) 107 (69–217) 0.05 68 (48–95) 80 (49–117) 71 (54–81) 95 (58–137)
Fasting insulin (pmol/l)b 171 (26–603) 183 (79–596) 0.56 155 (72–237) 183 (79–545) 117 (108–151) 159 (86–215)
Pedometer (steps/day) 7609+2313 6373+2873 0.22 9633+2505 7489+3406 10528+2109 9024+2417
Comparison of baseline characteristics and characteristics of RO+ and RO2 women at month 3 and month 6 are given.
Data expressed as amean+ SD were analysed using the independent samples Student’s t-test; data expressed as bmedian, minimum and maximum were analysed using the
Mann–Whitney U-test.
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Moreover, our study shows that early and consistent loss of IAF
over a 6-month period is associated with resumption of ovulation.
Only after more than 3 months of lifestyle intervention, RO+
women started losing more SAF than RO2 women. Previous
studies in different patient populations have shown that during the
initial period of calorie restriction, preferential loss of IAF occurs
which correlates signiﬁcantly with improvement in IR (Goodpaster
et al., 1999; Park and Lee, 2005). Loss of IAF and not SAF during
initial calorie restriction, can be explained by increased lipolysis of
IAF due to its higher metabolic activity (Smith and Zachwieja, 1999).
After surgical removal of IAF, IR has been shown to improve
(Thorne et al., 2002), while removal of SAF by liposuction does not
signiﬁcantly alter IR (Klein et al., 2004). Based on the above-mentioned
mechanism, the early and consistent loss of IAF in RO+ women might
have contributed to improvement in IR and resumption of ovulation.
We could not conﬁrm the expected difference in fasting insulin
levels between RO+ and RO2 women in our study, which may be
due to the high average BMI in our population. Moderate weight
loss in women with BMI .35 kg/m2 does not always lead to the
same decrease in fasting insulin levels as in women with lower BMI,
as shown in a previous study in women with PCOS and obesity
(Tang et al., 2006).
We have previously shown that in women with obesity and inferti-
lity, anovulatory women have signiﬁcantly more SAF and higher fasting
insulin levels and the same amount of IAF compared with ovulatory
women with the same BMI (Kuchenbecker et al., 2010). A possible
explanation for an increased volume of SAF in anovulatory women
with obesity could be provided by the concept of a critical IAF
threshold. This concept suggests that during constant high calorie
food consumption, storage of fat in IAF reaches a point of saturation,
after which fat is shunted to the subcutaneous fat compartments
(Freedland, 2004). With increased accumulation of SAF, inﬂammatory
changes and increase in adipocyte size occur, limiting the SAF storage
capacity and contributing to the antilipolytical effects of insulin. Fat is
then shunted from SAF to the liver and skeletal muscle which contrib-
utes to increased IR (Weiss, 2007; Koska et al., 2008). During a period
of reduced calorie intake, fat is rapidly mobilized from IAF, liver fat and
skeletal muscle fat due to the higher lipolytical activity of these fat
Figure 1 Baseline corrected GEE analysis of 32 anovulatory
women with PCOS and obesity undergoing a lifestyle program with
post hoc allocation of participants into those who resumed ovulation
(RO+) and those who remained anovulatory (RO2) at the end of 6
months shows a difference in loss of body weight (P ¼ 0.018) (a) and
abdominal fat on DEXA (P ¼ 0.025) and (b) between RO+ (solid
line) and RO2 (dashed line) participants. Error bars indicate standard
errors of GEE estimates.
Figure 2 Baseline-corrected GEE analysis of 32 anovulatory
women with PCOS and obesity undergoing a lifestyle program with
post hoc allocation of participants into those who resumed ovulation
(RO+) and those who remained anovulatory (RO2) at the end of 6
months show a difference in loss of IAF from month 0 to month 3
(P ¼ 0.002) (a) and from month 0 to month 6 (P ¼ 0.005) (a), and
difference in loss of SAF from month 0 to month 3 (P ¼ 0.946) (b)
and from month 0 to month 6 (P ¼ 0.031) and (b) between RO+
(solid line) and RO2 (dashed line) participants. Error bars indicate
standard errors of GEE estimates.
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compartments. This mobilization of fat from IAF, liver fat and skeletal
muscle fat leads to improved IR (Goodpaster et al., 1999; Freedland,
2004). This mechanism could also explain the ﬁndings of the present
study that early and consistent loss of IAF and not SAF was associated
with resumption of ovulation.
Previous studies suggest that exercise contributes to loss of IAF
(Kay and Fiatarone Singh, 2006; Ohkawara et al., 2007) while
another study could not show an independent effect of exercise on
loss of IAF (Christiansen et al., 2009). In anovulatory women with
PCOS, a structured exercise program showed higher ovulation rates
and improvement in IR compared with a diet program alone
(Palomba et al., 2008). A more recent study showed that exercise
was associated with loss of IAF and improvement in IR in PCOS
women, despite weight maintenance. Using the euglycemic hyperinsu-
linemic clamp technique, no signiﬁcant correlation was found,
however, between improvement in IR and loss of IAF (Hutchison
et al., 2011). Exercise might also improve IR by increasing muscle
mass and enhancing glucose disposal in skeletal muscle (Carroll and
Dudﬁeld, 2004; Thomson et al., 2008). In the present study, we
cannot exclude that the non-signiﬁcant increase in pedometer steps
might have contributed to increased loss of IAF and resumption of
ovulation in the RO+ women compared with RO2 women.
As shown in previous studies, resumption of ovulation during weight
loss is associated with a decrease in fasting insulin and free testoster-
one levels (Guzick et al., 1994; Pasquali et al., 2006). In addition,
weight loss with improvement in IR, and therefore lower insulin
levels, leads to less androgen production by the ovarian theca cells
and more SHBG production in the liver (Poretsky, 1991). Lower
free androgen levels in the long term, limits the amount of abdominal
fat accumulation (Pasquali et al., 2006; Bohler et al., 2010). In our
study, we found a decrease in free testosterone in the RO+
women that was not statistically signiﬁcant compared with RO2
women. This might be due to small numbers in our study.
This study shows that in anovulatory women with PCOS and
obesity participating in a lifestyle program, resumption of ovulation
is associated with early and consistent loss of IAF. The most likely
mechanism of resumption of ovulation after loss of IAF during a life-
style program is improvement of IR and lower free androgen levels
but other mechanisms should also be considered. Women with ano-
vulatory PCOS have altered adipocytokine secretion (Carmina et al.,
2009) and changes in the adipocytokine secretion due to loss of IAF
can also be considered as a mechanism of resumption of ovulation,
as these substances also have direct effects on the ovary (Mitchell
et al., 2005). Future studies should try to evaluate interventions
aimed at loss of IAF and should try to explore the mechanism involved
in resumption of ovulation due to loss of IAF.
The present study was a pilot to investigate the feasibility of a life-
style program in a tertiary fertility center. In spite of personal guidance
by a nurse practitioner using motivational interviewing techniques,
there was a high drop-out rate of 31.3%. Our drop-out rate is in
agreement with the rates of 27–35% reported in previous studies
on lifestyle intervention in comparable patient populations (Clark
et al., 1995; Hoeger et al., 2004; Palomba et al., 2008). Based on
follow-up data until 6 months after drop-out, we decided to allocate
the drop-outs to the RO2 group until the moment of drop-out.
This decision was based on the fact that resumption of ovulation is
highly unlikely in anovulatory women with obesity who do not lose
weight (Clark et al., 1995). We can however not exclude the possi-
bility that women in the drop-out group had occasional ovulation in
spite of no further weight loss. The high drop-out rate deserves
further evaluation in order to improve the effectiveness of lifestyle
programs. If predictive factors for drop-out in this patient population
could be indentiﬁed (Teixeira et al., 2005), speciﬁc personal guidance
and intervention should be developed to improve motivation and
adherence to diet—and exercise programs to achieve weight loss.
In conclusion, this study indicates that anovulatory women with
PCOS and obesity who resume ovulation during a lifestyle program
lose 4 kg (3.3%) more weight and 0.5 kg (10.7%) more abdominal
fat on DEXA than the women who remain anovulatory. Moreover,
early and consistent loss of IAF is associated with resumption of
ovulation.
Future larger studies on lifestyle interventions in anovulatory
women with PCOS should aim to conﬁrm our ﬁndings and to evaluate
the mechanisms of resumption of ovulation. Trials should be designed
to assess the combination of diet and structured exercise programs
aimed at loss of IAF and improvement of IR for resumption of ovu-
lation, thereby decreasing the number of infertile women requiring
ovulation induction.
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